Frankfurt - Delayed Quote EUR

BioNTech SE (22UA.F)

83.75
+0.80
+(0.96%)
As of 7:20:38 PM GMT+2. Market Open.

Research Analysis

Revenue vs. Earnings

Revenue 182.8M
Earnings -415.8M

Q2'24

Q3'24

Q4'24

Q1'25

-500M
0
500M
1B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in EUR Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 11112019
Avg. Estimate 136.87M763.27M2.07B2.2B
Low Estimate 82.26M486M1.7B1.42B
High Estimate 406.4M1.23B2.73B3.54B
Year Ago Sales 128.7M1.24B2.75B2.07B
Sales Growth (year/est) 6.35%-38.68%-24.72%5.99%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
22UA.F --------
S&P 500 12.66%3.22%7.99%13.82%

Upgrades & Downgrades

Maintains Citigroup: Buy to Buy 5/6/2025
Maintains Morgan Stanley: Overweight to Overweight 5/6/2025
Maintains HC Wainwright & Co.: Buy to Buy 4/1/2025
Initiated Citigroup: Buy 3/13/2025
Maintains Morgan Stanley: Overweight to Overweight 3/11/2025
Maintains Canaccord Genuity: Buy to Buy 3/11/2025

Related Tickers